期刊
BMC CARDIOVASCULAR DISORDERS
卷 19, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s12872-019-1144-x
关键词
Non-vitamin K antagonist oral anticoagulants; Real-world; Registry; Stroke prevention; Major bleeding; Safety outcomes
资金
- Daiichi Sankyo Europe GmbH, Munich, Germany
BackgroundNon-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have substantially improved anticoagulation therapy for prevention of stroke and systemic embolism in patients with atrial fibrillation (AF). The available routine care data have demonstrated the safety of different NOACs; however, such data for edoxaban are scarce. Here, we report baseline characteristics of 13,638 edoxaban-treated patients with AF enrolled between November 2016 and February 2018.MethodsETNA-AF-Europe is a multinational, multi-centre, post-authorisation, observational study conducted in 825 sites in 10 European countries. Patients will be followed up for four years.ResultsOverall, 13,980 patients were enrolled of which 342 patients were excluded from the analysis. Mean patient age was 73.6years with an average creatinine clearance of 69.4mL/min. 56.6% were male. The calculated CHA(2)DS(2)-VASc and HAS-BLED mean scores were 3.1 and 2.6, respectively. Overall, 3.3, 14.6 and 82.0% of patients had low (CHA(2)DS(2)-VASc=0), intermediate (CHA(2)DS(2)-VASc=1) and high (CHA(2)DS(2)-VASc >= 2) risks of stroke, respectively. High-risk patients (those with prior stroke, prior major bleeding, prior intracranial bleed or CHA(2)DS(2)-VASc >= 4) comprised 38.4% of the overall population. For 75.1% of patients edoxaban was their first anticoagulant prescription, whilst 16.9% switched from a VKA and 8.0% from another NOAC. A total of 23.4% of patients in ETNA-AF-Europe received the reduced dose of edoxaban 30mg. Overall, 83.8% of patients received an edoxaban dose in line with the criteria outlined in the label.ConclusionEdoxaban was predominantly initiated in older, often anticoagulation-naive, unselected European patients with AF, with a good overall adherence to the approved label.Trial registrationNCT02944019; Date of registration: October 24, 2016.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据